Details of the Drug

General Information of Drug (ID: DM8KRA3)

Drug Name

EDP-514

Indication

Disease Entry	ICD 11	Status	REF
Chronic HBV infection	1E51.0Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis B virus Capsid protein (HBV C)	TTM42UJ	CAPSD_HBVD3	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04470388) A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Enanta Pharmaceuticals.